NCT01615406View on ClinicalTrials.gov

A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

November 30, 2012

Conditions
Prostate Cancer
Interventions
DRUG

99mTc MIP 1404

A single dose of 20 ±3 mCi intravenous (IV) injection of 99mTc MIP 1404

Trial Locations (1)

77030

The University of Texas Health Science Center - Houston, Houston

Sponsors
All Listed Sponsors
lead

Molecular Insight Pharmaceuticals, Inc.

INDUSTRY